JZP150 for Post Traumatic Stress Disorder

Phase-Based Progress Estimates
Post Traumatic Stress DisorderJZP150 - Drug
18 - 70
All Sexes
What conditions do you have?

Study Summary

This trial will study whether JZP150 is a safe and effective treatment for adults with PTSD.

Eligible Conditions
  • Post Traumatic Stress Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Baseline to Week 12

Baseline to Week 12
Mean Change from Baseline to Week 12 in Clinical Global Impression of Severity (CGI-S)
Mean Change from Baseline to Week 12 in Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS-5) Total Symptom Severity Score
Mean Change from Baseline to Week 12 in Patient Global Impression of Severity (PGI-S)

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

3 Treatment Groups

JZP150 0.3 mg
1 of 3
JZP150 4.0 mg
1 of 3
1 of 3

Experimental Treatment

Non-Treatment Group

270 Total Participants · 3 Treatment Groups

Primary Treatment: JZP150 · Has Placebo Group · Phase 2

JZP150 0.3 mg
Experimental Group · 1 Intervention: JZP150 · Intervention Types: Drug
JZP150 4.0 mg
Experimental Group · 1 Intervention: JZP150 · Intervention Types: Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to week 12

Who is running the clinical trial?

Jazz PharmaceuticalsLead Sponsor
218 Previous Clinical Trials
29,999 Total Patients Enrolled

Eligibility Criteria

Age 18 - 70 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
People who want to participate in the study must be outpatients who have been diagnosed with post-traumatic stress disorder (PTSD) according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)

Who else is applying?

What state do they live in?
How old are they?
18 - 6590.0%
What site did they apply to?
Austin Clinical Trial Partners14.3%
Clinical Trials of Texas28.6%
Altea Research14.3%
What portion of applicants met pre-screening criteria?
Met criteria66.7%
Did not meet criteria33.3%

How responsive is this trial?

Most responsive sites:
  1. EZY Medical Research Co: < 48 hours
Average response time
  • < 2 Days
Typically responds via